Drug-related catatonia in youths: real-world insights from the WHO Safety Database.
Saved in:
| Title: | Drug-related catatonia in youths: real-world insights from the WHO Safety Database. |
|---|---|
| Authors: | Merino, Diane, Gérard, Alexandre O., Lavrut, Thibaud, Askenazy, Florence, Thümmler, Susanne, Montastruc, François, Drici, Milou-Daniel |
| Source: | European Child & Adolescent Psychiatry. May2024, Vol. 33 Issue 5, p1383-1393. 11p. |
| Subjects: | World Health Organization, Pharmacology, Ondansetron, Patient safety, Cyclosporine, Olanzapine, Child psychiatry, Descriptive statistics, Haloperidol, Odds ratio, Chlorpromazine, Benztropine, Catatonia, Confidence intervals, Vaccines, Adolescence, Children |
| Abstract: | Catatonia is characterized by psychomotor alterations and reduced contact with the environment. Initially linked to schizophrenia, it also occurs in mood disorders or organic conditions. In children, catatonia remains poorly delineated, despite dramatically increasing the risk of premature death. As data on pediatric drug-induced catatonia bears many uncertainties, we aimed to characterize its age-dependent patterns, using real-world data from the WHO safety database (VigiBase®).VigiBase® was queried for all reports of catatonia registered up to December 8th 2022. Reports involving patients <18 years were classified into 3 groups: ≤23 months, 2–11 years, and 12–17 years. Disproportionality analyses relied on the Reporting Odds Ratio (ROR), and the positivity of the lower end of the 95% confidence interval of the Information Component (IC) was required to suspect a signal. Catatonia was evoked in 421 pediatric reports. In infants, vaccines were leading. In children, the main signals involved haloperidol (ROR 104.3; 95% CI 45.6–238.5), ondansetron (ROR 40.5; 95% CI 16.5–99.5), and ciclosporin (ROR 27.4; 95% CI 13.8–54.1). In adolescents, chlorpromazine (ROR 199.1; 95% CI 134.8–294.1), benzatropine (ROR 193; 95% CI 104.1–361.6), and olanzapine (ROR 135.7; 95% CI 104.6–175.9) reached the highest RORs. In infants, catatonia was related to vaccines, it was ascribed to multiple drugs in children, and mainly to psychotropic drugs in adolescents. Less suspected drugs, such as ondansetron, were highlighted. Despite limitations inherent in spontaneous reporting systems, this study supports that a careful anamnesis is warranted to separate catatonia associated with medical conditions from drug-induced catatonia in pediatric patients. [ABSTRACT FROM AUTHOR] |
| Copyright of European Child & Adolescent Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 178046250 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Drug-related catatonia in youths: real-world insights from the WHO Safety Database. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Merino%2C+Diane%22">Merino, Diane</searchLink><br /><searchLink fieldCode="AR" term="%22Gérard%2C+Alexandre+O%2E%22">Gérard, Alexandre O.</searchLink><br /><searchLink fieldCode="AR" term="%22Lavrut%2C+Thibaud%22">Lavrut, Thibaud</searchLink><br /><searchLink fieldCode="AR" term="%22Askenazy%2C+Florence%22">Askenazy, Florence</searchLink><br /><searchLink fieldCode="AR" term="%22Thümmler%2C+Susanne%22">Thümmler, Susanne</searchLink><br /><searchLink fieldCode="AR" term="%22Montastruc%2C+François%22">Montastruc, François</searchLink><br /><searchLink fieldCode="AR" term="%22Drici%2C+Milou-Daniel%22">Drici, Milou-Daniel</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Child+%26+Adolescent+Psychiatry%22">European Child & Adolescent Psychiatry</searchLink>. May2024, Vol. 33 Issue 5, p1383-1393. 11p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22World+Health+Organization%22">World Health Organization</searchLink><br /><searchLink fieldCode="DE" term="%22Pharmacology%22">Pharmacology</searchLink><br /><searchLink fieldCode="DE" term="%22Ondansetron%22">Ondansetron</searchLink><br /><searchLink fieldCode="DE" term="%22Patient+safety%22">Patient safety</searchLink><br /><searchLink fieldCode="DE" term="%22Cyclosporine%22">Cyclosporine</searchLink><br /><searchLink fieldCode="DE" term="%22Olanzapine%22">Olanzapine</searchLink><br /><searchLink fieldCode="DE" term="%22Child+psychiatry%22">Child psychiatry</searchLink><br /><searchLink fieldCode="DE" term="%22Descriptive+statistics%22">Descriptive statistics</searchLink><br /><searchLink fieldCode="DE" term="%22Haloperidol%22">Haloperidol</searchLink><br /><searchLink fieldCode="DE" term="%22Odds+ratio%22">Odds ratio</searchLink><br /><searchLink fieldCode="DE" term="%22Chlorpromazine%22">Chlorpromazine</searchLink><br /><searchLink fieldCode="DE" term="%22Benztropine%22">Benztropine</searchLink><br /><searchLink fieldCode="DE" term="%22Catatonia%22">Catatonia</searchLink><br /><searchLink fieldCode="DE" term="%22Confidence+intervals%22">Confidence intervals</searchLink><br /><searchLink fieldCode="DE" term="%22Vaccines%22">Vaccines</searchLink><br /><searchLink fieldCode="DE" term="%22Adolescence%22">Adolescence</searchLink><br /><searchLink fieldCode="DE" term="%22Children%22">Children</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Catatonia is characterized by psychomotor alterations and reduced contact with the environment. Initially linked to schizophrenia, it also occurs in mood disorders or organic conditions. In children, catatonia remains poorly delineated, despite dramatically increasing the risk of premature death. As data on pediatric drug-induced catatonia bears many uncertainties, we aimed to characterize its age-dependent patterns, using real-world data from the WHO safety database (VigiBase®).VigiBase® was queried for all reports of catatonia registered up to December 8th 2022. Reports involving patients <18 years were classified into 3 groups: ≤23 months, 2–11 years, and 12–17 years. Disproportionality analyses relied on the Reporting Odds Ratio (ROR), and the positivity of the lower end of the 95% confidence interval of the Information Component (IC) was required to suspect a signal. Catatonia was evoked in 421 pediatric reports. In infants, vaccines were leading. In children, the main signals involved haloperidol (ROR 104.3; 95% CI 45.6–238.5), ondansetron (ROR 40.5; 95% CI 16.5–99.5), and ciclosporin (ROR 27.4; 95% CI 13.8–54.1). In adolescents, chlorpromazine (ROR 199.1; 95% CI 134.8–294.1), benzatropine (ROR 193; 95% CI 104.1–361.6), and olanzapine (ROR 135.7; 95% CI 104.6–175.9) reached the highest RORs. In infants, catatonia was related to vaccines, it was ascribed to multiple drugs in children, and mainly to psychotropic drugs in adolescents. Less suspected drugs, such as ondansetron, were highlighted. Despite limitations inherent in spontaneous reporting systems, this study supports that a careful anamnesis is warranted to separate catatonia associated with medical conditions from drug-induced catatonia in pediatric patients. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of European Child & Adolescent Psychiatry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=178046250 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00787-023-02234-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 1383 Subjects: – SubjectFull: World Health Organization Type: general – SubjectFull: Pharmacology Type: general – SubjectFull: Ondansetron Type: general – SubjectFull: Patient safety Type: general – SubjectFull: Cyclosporine Type: general – SubjectFull: Olanzapine Type: general – SubjectFull: Child psychiatry Type: general – SubjectFull: Descriptive statistics Type: general – SubjectFull: Haloperidol Type: general – SubjectFull: Odds ratio Type: general – SubjectFull: Chlorpromazine Type: general – SubjectFull: Benztropine Type: general – SubjectFull: Catatonia Type: general – SubjectFull: Confidence intervals Type: general – SubjectFull: Vaccines Type: general – SubjectFull: Adolescence Type: general – SubjectFull: Children Type: general Titles: – TitleFull: Drug-related catatonia in youths: real-world insights from the WHO Safety Database. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Merino, Diane – PersonEntity: Name: NameFull: Gérard, Alexandre O. – PersonEntity: Name: NameFull: Lavrut, Thibaud – PersonEntity: Name: NameFull: Askenazy, Florence – PersonEntity: Name: NameFull: Thümmler, Susanne – PersonEntity: Name: NameFull: Montastruc, François – PersonEntity: Name: NameFull: Drici, Milou-Daniel IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: May2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 10188827 Numbering: – Type: volume Value: 33 – Type: issue Value: 5 Titles: – TitleFull: European Child & Adolescent Psychiatry Type: main |
| ResultId | 1 |